May increase the risk of hypoglycemia; dose adjustment and increased glucose monitoring required.
Source: NLP:insulin lispro
Pramlintide Interactions
11 interactions on record
Pramlintide + GlimepirideModerate
May increase the glucose-lowering effect of glimepiride, increasing susceptibility to hypoglycemia.
Source: NLP:glimepiride
Pramlintide + GlipizideModerate
May increase glucose-lowering effect of glipizide and susceptibility to hypoglycemia; monitor closely.
Source: NLP:glipizide
May increase the risk of hypoglycemia. Dose adjustment and increased glucose monitoring required.
Source: NLP:insulin aspart
May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Source: NLP:insulin aspart-szjj
Pramlintide + Insulin DegludecModerate
May increase risk of hypoglycemia. Dosage reductions and increased glucose monitoring may be required.
Source: NLP:insulin degludec
Pramlintide + Insulin GlargineModerate
May increase risk of hypoglycemia; dosage reductions and increased glucose monitoring may be required.
Source: NLP:insulin glargine
Pramlintide + Insulin GlulisineModerate
May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Source: NLP:insulin glulisine
Pramlintide + Insulin HumanModerate
May increase risk of hypoglycemia; dose adjustment and increased glucose monitoring may be required.
Source: NLP:insulin human
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin lispro-aabc
Pramlintide + RepaglinideModerate
May increase risk of hypoglycemia. Repaglinide dose reductions and increased glucose monitoring may be required.
Source: NLP:repaglinide